Hand foot skin reaction (HFSR) by the multikinase inhibitors (MKIs) sorafenib and sunitinib: Impact on quality of life (QoL)
In: Journal of Clinical Oncology, Jg. 26 (2008-05-20), S. 16122-16122
Online
unknown
Zugriff:
16122 Background: The MKIs sorafenib and sunitinib have shown a survival advantage in a variety of solid tumors. However, their use is hampered by the occurrence of HFSR in 20–30% of patients (pts)...
Titel: |
Hand foot skin reaction (HFSR) by the multikinase inhibitors (MKIs) sorafenib and sunitinib: Impact on quality of life (QoL)
|
---|---|
Autor/in / Beteiligte Person: | Huggins, R. H. ; Kuzel, Timothy M. ; West, Dennis P. ; Lacouture, Mario E. ; Anderson, Roger T. |
Link: | |
Zeitschrift: | Journal of Clinical Oncology, Jg. 26 (2008-05-20), S. 16122-16122 |
Veröffentlichung: | American Society of Clinical Oncology (ASCO), 2008 |
Medientyp: | unknown |
ISSN: | 1527-7755 (print) ; 0732-183X (print) |
DOI: | 10.1200/jco.2008.26.15_suppl.16122 |
Schlagwort: |
|
Sonstiges: |
|